Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epidemiology and pathobiology of SARS-CoV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future perspectives
Balasubramanian Ganesh, Thangarasu Rajakumar, Malathi Mathiyazhakan, et al.
Clinical Epidemiology and Global Health (2021) Vol. 10, pp. 100694-100694
Open Access | Times Cited: 117

Showing 1-25 of 117 citing articles:

Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies
Kuldeep Dhama, Firzan Nainu, Andri Frediansyah, et al.
Journal of Infection and Public Health (2022) Vol. 16, Iss. 1, pp. 4-14
Open Access | Times Cited: 199
Hyperinflammatory Immune Response and COVID-19: A Double Edged Sword
Li Yin Tan, Thamil Vaani Komarasamy, Vinod Balasubramaniam
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 131
Anti-SARS-CoV-2 Receptor-Binding Domain Total Antibodies Response in Seropositive and Seronegative Healthcare Workers Undergoing COVID-19 mRNA BNT162b2 Vaccination
Gian Luca Salvagno, Brandon Michael Henry, Giovanni Di Piazza, et al.
Diagnostics (2021) Vol. 11, Iss. 5, pp. 832-832
Open Access | Times Cited: 90
SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants
John Charles Rotondo, Fernanda Martini, Martina Maritati, et al.
Viruses (2021) Vol. 13, Iss. 9, pp. 1687-1687
Open Access | Times Cited: 75
Waning antibody responses in COVID-19: what can we learn from the analysis of other coronaviruses?
Ali Hamady, JinJu Lee, Zuzanna Loboda
Infection (2021) Vol. 50, Iss. 1, pp. 11-25
Open Access | Times Cited: 67
A nanogap-enhanced SERS nanotag–based lateral flow assay for ultrasensitive and simultaneous monitoring of SARS-CoV-2 S and NP antigens
Xiaoxian Liu, Xingsheng Yang, Chongwen Wang, et al.
Microchimica Acta (2024) Vol. 191, Iss. 2
Closed Access | Times Cited: 9
Factors Affecting Initial Humoral Immune Response to SARS-CoV-2 Vaccines Among Patients With Inflammatory Bowel Diseases
Michael D. Kappelman, Kimberly N. Weaver, Xian Zhang, et al.
The American Journal of Gastroenterology (2021) Vol. 117, Iss. 3, pp. 462-469
Closed Access | Times Cited: 40
Strong Response to SARS-CoV-2 Vaccine Additional Doses Among Patients With Inflammatory Bowel Diseases
Millie D. Long, Kimberly N. Weaver, Xian Zhang, et al.
Clinical Gastroenterology and Hepatology (2022) Vol. 20, Iss. 8, pp. 1881-1883.e1
Open Access | Times Cited: 33
Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications
Lijun Chen, Jingjing Qu, Farhin Shaheed Kalyani, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Open Access | Times Cited: 33
IoT-fog-based healthcare 4.0 system using blockchain technology
Israr Ahmad, Saima Abdullah, Adeel Ahmed
The Journal of Supercomputing (2022) Vol. 79, Iss. 4, pp. 3999-4020
Open Access | Times Cited: 31
Nanostructures for drug delivery in respiratory diseases therapeutics: Revision of current trends and its comparative analysis
Luis Ángel Ibarra-Sánchez, Ana María Gámez-Méndez, Manuel Martínez-Ruiz, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 70, pp. 103219-103219
Open Access | Times Cited: 29
Comorbidities of COVID-19 Patients
Radu Silaghi‐Dumitrescu, Iulia Patrascu, Maria Lehene, et al.
Medicina (2023) Vol. 59, Iss. 8, pp. 1393-1393
Open Access | Times Cited: 19
The Respiratory Mechanics of COVID-19 Acute Respiratory Distress Syndrome—Lessons Learned?
Rebecca L. Kummer, John J. Marini
Journal of Clinical Medicine (2024) Vol. 13, Iss. 7, pp. 1833-1833
Open Access | Times Cited: 6
Uncovering the Binding Mechanism of Mutated Omicron Variants via Computational Strategies
Sajjad Haider, Nadeem Ahmad, Muhammad Shafiq, et al.
ACS Omega (2025)
Open Access
COVID-19 clinical presentation, management, and epidemiology: a concise compendium
David P. Maison, Hawi Tasissa, Amelia N. Deitchman, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access
Antibodies against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) in individuals with and without COVID-19 vaccination: A method comparison of two different commercially available serological assays from the same manufacturer
Thomas Mueller
Clinica Chimica Acta (2021) Vol. 518, pp. 9-16
Open Access | Times Cited: 36
COVID-19 mortality and exposure to airborne PM2.5: A lag time correlation
Longyi Shao, Yaxin Cao, Timothy Peter Jones, et al.
The Science of The Total Environment (2021) Vol. 806, pp. 151286-151286
Open Access | Times Cited: 35
Serum biomarkers for nutritional status as predictors in COVID-19 patients before and after vaccination
Rita Vaz‐Rodrigues, Lorena Mazuecos, Margarita Villar, et al.
Journal of Functional Foods (2023) Vol. 101, pp. 105412-105412
Open Access | Times Cited: 13
Anti-SARS-CoV-2 activity of various PET-bottled Japanese green teas and tea compounds in vitro
Mya Myat Ngwe Tun, Elizabeth Luvai, Khine Mya Nwe, et al.
Archives of Virology (2022) Vol. 167, Iss. 7, pp. 1547-1557
Open Access | Times Cited: 19
SARS-CoV-2, COVID-19, and Reproduction: Effects on Fertility, Pregnancy, and Neonatal Life
Julien Harb, Nour Debs, Mohamad Rima, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1775-1775
Open Access | Times Cited: 19
The Mental Health Impacts of a Pandemic: A Multiaxial Conceptual Model for COVID-19
David Dias Neto, Ana Nunes da Silva
Behavioral Sciences (2023) Vol. 13, Iss. 11, pp. 912-912
Open Access | Times Cited: 9
The three syndromes and six Chinese patent medicine study during the recovery phase of COVID-19
Xuedong An, Liyun Duan, Yue Hong Zhang, et al.
Chinese Medicine (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 22
Tea Polyphenols Prevent and Intervene in COVID-19 through Intestinal Microbiota
Qiao Xiang, Lu Cheng, Ruilin Zhang, et al.
Foods (2022) Vol. 11, Iss. 4, pp. 506-506
Open Access | Times Cited: 15
SARS-CoV-2 Dysregulates Neutrophil Degranulation and Reduces Lymphocyte Counts
Abenaya Muralidharan, Todd A. Wyatt, St Patrick Reid
Biomedicines (2022) Vol. 10, Iss. 2, pp. 382-382
Open Access | Times Cited: 14
The evolving epidemiology of SARS-CoV-2
Catherine Bennett, Hassan Vally
Microbiology Australia (2024), pp. NULL-NULL
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top